Clinical Trials Browser

Phase 2 × Gastrointestinal Neoplasms × camrelizumab × Clear all

NCT05225844 2022-02-07

An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal

Phase 2 Unknown

Gastrointestinal

Gastrointestinal Neoplasms